E6 Todd Davenport discusses the overlap between Long COVID and ME/CFS, emphasizing differing pathogens, bioenergetic dysfunction, and diagnostic challenges, while advocating for patient history, symptom validation, and pacing strategies for management.
This research conducted interviews via telemedicine of 165 patients with Long COVID over a 2-year time frame.
Researchers are looking at whether medications used to treat or prevent HIV may also alleviate long Covid symptoms.
Chimére L Sweeney emphasizes the need for awareness, stating, "I want to help Black people tell their stories of long covid." The discussion highlights the importance of empathy and support for those affected, advocating for better healthcare access and understanding.
E5 Personal Long COVID Story & Advocacy ft. Gez Medinger In this episode, Gez Medinger discusses the complexities of Long COVID, the differences in vaccine responses, and the need for a more holistic medical approach. He also highlights his research, shared on YouTube and in his book, "The Long COVID Handbook," and the need for
Post-exertional malaise (PEM) stands as a defining and often debilitating feature of Long COVID, PEM report a range of symptoms, including heightened fatigue, cognitive fog, muscle and joint pain, and a general sense of unwellness
E4 Diagnosing and Managing Long COVID in Children ft. Danilo Buonsenso MD PhD Dr. Danilo Buonsenso discusses diagnosing and managing Long COVID in children. He highlights similarities in symptoms between children and adults, the underdiagnosis of Long COVID, its prevalence, age and gender differences, diagnostic challenges, and the need for a multi-disciplinary approach in community
Danielle Beckham Neuroscientist at the @CNPRCresearch . MS in Biophysics, PhD in Biological Chemistry. With her latest entry to NeuroArt "Unwelcome guest: SARS-Cov-2" - If you like it, please vote!
This research concludes that ANTIVIRALS reduced the risk of developing Long COVID and should be recommended to treat an acute COVID infection ....
They looked at the pre-delta, delta and omicron eras of infection with SARS-CoV-2 and showed that the risk of Long COVID decreased over the course of the pandemic from 10% to 8% in unvaccinated persons. The results of this trial have been talked about on social media with a lot of disappointment as Paxlovid didn’t
